Long-term antibiotic therapy for balanitis xerotica obliterans

Journal of the American Academy of Dermatology

Volumn 40, Issue 1, 1999, Pages 69-72

  Shelley, W B ^a   Shelley, E D ^a   Grunenwald, M A ^a   Anders, T J ^a   Ramnath, A ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; DIRITHROMYCIN; PENICILLIN V POTASSIUM;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BALANITIS; CASE REPORT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LONG TERM CARE; MALE; ORAL DRUG ADMINISTRATION; PENIS GLANS; PRIORITY JOURNAL; PRURITUS; SKIN BIOPSY; SKIN INFLAMMATION; TREATMENT OUTCOME;

EID: 0033011626     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70529-3     Document Type: Article

References (35)

1. CW Laymon C Freeman Relationship of balanitis xerotica obliterans to lichen sclerosus et atrophicus Arch Dermatol Syphilol 49 1994 57 59
2. JJ Meffert BM David RD Grinwood Lichen sclerosus J Am Acad Dermatol 32 1995 393 416
3. HB Prede OF Miller III WB Tyler Penile squamous cell carcinoma arising from balanitis xerotica obliterans J Am Acad Dermatol 29 1993 469 473
4. WB Shelley ED Shelley Advanced dermatologic therapy 1987 WB Saunders Philadelphia 94 95
5. PM Bale A Lochhead HCO Martin I Gollow Balanitis xerotica obliterans in children Pediatr Pathol 7 1987 617 627
6. KA Arndt JS Dover SM Olbricht Lasers in cutaneous and aesthetic surgery 1997 Lippincott-Raven Philadelphia 243
7. FH Hinman Jr Atlas of urologic surgery 2nd ed 1998 WB Saunders Philadelphia 266 267
8. C Schempp H Bocklage R Lange Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification J Invest Dermatol 100 1993 717 720
9. E Aberer H Kollegger W Kristoferitsch G Stanek Neuroborreliosis in morphea and lichen sclerosus et atrophicus J Am Acad Dermatol 19 1998 820 825
10. K Weber V Preac-Mursic CD Reimers Spirochetes isolated from two patients with morphea Infection 16 1998 25 26
11. J Uitto DJ Santa Cruz EA Bauer AZ Eisen Morphea and lichen sclerosus et atrophicus: clinical and histopathologic studies in patients with combined features J Am Acad Dermatol 3 1980 271 279
12. PH Duray AC Steere Clinical pathologic correlations of Lyme disease by stage Ann NY Acad Sci 539 1978 65 79
13. MS Malane JM Grant-Kels HM Feder Jr SW Luger Diagnosis of Lyme disease based on dermatologic manifestations Ann Intern Med 114 1991 490 498
14. E Aberer R Neumann G Lubec Acrodermatitis chronica atrophicans in association with lichen sclerosus et atrophicans: tubulo-interstitial nephritis and urinary excretion of spirochete-like organisms Acta Derm Venereol (Stockh) 67 1987 62 65
15. PH Duray E Asbrink K Weber The cutaneous manifestations of human Lyme disease: a widening spectrum Adv Dermatol 4 1989 255 276
16. N Thyresson The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer) Acta Derm Venereol (Stockh) 29 1949 572 6621
17. E Asbrink A Hovmark B Hederstedt The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer Acta Derm Venereol (Stockh) 64 1984 506 512
18. E Aberer H Klade G Stanek W Gebhart Borrelia burgdorferi and different types of morphea Dermatologica 182 1991 145 154
19. TG Schwan W Burgdorfer ME Schrumpf RH Karstens The urinary bladder, a consistent source of Borrelia burgdorferi in experimentally infected white-foot mice (Peromyscus leucopus) J Clin Microbiol 26 1988 893 895
20. PA Ledwig DA Weigand Late circumcision and lichen sclerosus et atrophicus of the penis J Am Acad Dermatol 20 1989 211 214
21. DL Tuffanelli LR Tuffanelli A Hoke False-positive Lyme antibody test in morphea J Am Acad Dermatol 28 1993 112 113
22. JF Meis R Koopman B Van Bergen No evidence for a relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea) Arch Dermatol 129 1993 386 387
23. G Raguin S Boisnic P Souteyrand No evidence for a spirochaetal origin of localized scleroderma Br J Dermatol 127 1992 218 220
24. J Schmidli J Meyer Lyme borreliosis Dermatologica 182 1991 141 144
25. G Stanek G Wewalka V Groh Differences between Lyme disease and European arthropod-borne Borrelia infections [letter] Lancet 1 1985 401
26. F Dressler R Ackermann AC Steere Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis J Infect Dis 169 1994 313 318
27. Y Hashimoto N Kawagishi H Sakai Lyme disease in Japan: analysis of Borrelia species using r RNA gene restruction fragment length polymorphism Dermatologica 191 1995 193 198
28. FW Hyde RC Johnson TJ White CE Shelburne Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease J Clin Microbiol 27 1989 56 61
29. JL Goodman P Jurkovich JM Kramber RC Johnson Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease Infect Immun 59 1991 269 278
30. LH Sigal Lyme disease: a review of aspects of its immunology and immunopathogenesis Ann Immunol 15 1997 63 92
31. K Georgilis M Peacocke MS. Klempner Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro J Infect Dis l66 1992 440 444
32. Y Ma A Sturrock JJ Weiss Intracellular localization of Borrelia burgdorferi within human endothelial cells Infect Immun 59 1991 671 678
33. RR Montgomery MH Nathanson SE Malawista The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages J Immunol 150 1993 909 915
34. WE Hauser Jr JS Remington Effect of antimicrobial agents on the immune response Ristuccia AM, Cunha BA. Antimicrobial therapy 1984 Raven Press New York 55 79
35. D Vazquez The macrolide antibiotics JW Corcoran FE Hahn Antibiotics; vol 3—Mechanism of action of antimicrobial and antitumor agents 1975 Springer-Verlag Berlin 459 479